Millions of people suffer from rosacea, a relatively common inflammatory condition that can make the face undesirably ruddy and bumpy. Fortunately, in recent years, medical minds have made a huge leap in understanding and treating this frustrating skin problem.
Doctors have long been able to identify what triggers rosacea flare-ups-anything from spicy food to embarrassment-but they didn’t know why patients had the condition in the first place. Research from the University of California, San Diego School of Medicine highlights breakthrough evidence about the reasons behind the condition.
“Too much SCTE (stratum corneum tryptic enzymes) and too much cathelicidin leads to the abnormal peptides that cause the symptoms of this disease,” dermatology division chief Dr. Richard L. Gallo wrote in a study. Although this may not mean much to the layman, it means huge potential for doctors and pharmaceutical companies in their efforts to streamline treatment.
“Antibiotics tend to alleviate the symptoms of rosacea in patients because some of them work to inhibit these enzymes,” Gallo continued; however, “our findings may modify the therapeutic approach to treating rosacea, since bacteria aren’t the right target.”
Find a Doctor
Find a NewBeauty "Top Beauty Doctor" Near you